| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |